| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 33.60 | 0.20 (+0.61%) | 20.25 - 35.86 | 13.8 thousand (Above Avg) |
Market data as of 9:37AM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 33.62 |
|---|---|
| Previous Close | 33.39 |
| Day's Range | 33.39 - 33.67 |
| Market Cap | 2.0B |
| Avg Volume (10 Day) | 355.1K |
| Price/Earnings (Trailing 12 Mo.) | 30.9x |
| Earnings Per Share (Trailing 12 Mo.) | 1.08 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
ICON Reports First Quarter 2013 Revenue of $317 Million, up 26% year on year and non-GAAP EPS of 36c.
Business Wire - Thursday 04/25/2013 6:00 AM ET
ICON Wins ‘Partnership Pioneers of the Year’ Award in Recognition of Global Partnership with Pfizer
Business Wire - Wednesday 04/24/2013 6:00 AM ET
| ICLR | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 61.90% | |
| Net Income Growth (1yr) | 178.66% | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | 3.24% | |
| Price/Sales | 1.29 |
| Company | Last | Change |
|---|---|---|
| Alere Inc | 26.68 | +0.83% |
| WuXi Pharmatech (Cayman) Inc | 20.67 | -0.43% |
| PAREXEL International Corp | 46.47 | -0.21% |
| Ironwood Pharmaceuticals Inc | 13.52 | -2.24% |
| Genomic Health Inc | 37.25 | +0.11% |
Data is delayed by at least 15 min.